A

Al-Aqar Healthcare REIT
KLSE:ALAQAR

Watchlist Manager
Al-Aqar Healthcare REIT
KLSE:ALAQAR
Watchlist
Price: 1.38 MYR
Market Cap: 1.2B MYR
Have any thoughts about
Al-Aqar Healthcare REIT?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

17.8
Current
16.9
Median
11.5
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
17.8
=
Enterprise Value
1.8B MYR
/
EBITDA
103.1m MYR
All Countries
All Countries
Close
EBITDA Growth
MY
A
Al-Aqar Healthcare REIT
KLSE:ALAQAR
Average EV/EBITDA: 213.9
17.8
N/A
CA
A
Advance Lithium Corp
XTSX:AALI
Negative Multiple: -862 467.7 N/A
IN
S
SAB Industries Ltd
BSE:539112
734.2
N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
26%
US
Coupang Inc
F:788
53.9
264%
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
59.9
N/A
US
R
Reddit Inc
NYSE:RDDT
Negative Multiple: -35.7 N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
64%
IN
Jio Financial Services Ltd
NSE:JIOFIN
203.8
N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -137.9 N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
21.9
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A

See Also

Summary
ALAQAR intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALAQAR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALAQAR stock valuation using valuation multiples.
Wall Street Estimates
ALAQAR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALAQAR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 198,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.